Bioceltix S.A. (BCX.WA)

PLN 126.8

(2.26%)

Annual Income Statements

(In PLN)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - 10.8 Thousand 1500.00 9202.40
Cost of Revenue 1.03 Million 445.38 Thousand 376.97 Thousand 3.87 Million 3.48 Million 1.81 Million
Gross Profit -1.03 Million -445.38 Thousand -376.97 Thousand -3.86 Million -3.48 Million -1.8 Million
Operating Expenses 15.38 Million 9.22 Million 5.83 Million 121.86 Thousand 295.9 Thousand 114.13 Thousand
Selling, General and Administrative Expenses 11.5 Million 7.86 Million 5.8 Million 107.2 Thousand 272.43 Thousand 114 Thousand
Research and Development Expenses 3.84 Million 1.28 Million - - - -
Other Expenses -40.45 Thousand -83.52 Thousand -26.58 Thousand -14.66 Thousand -23.47 Thousand -130.00
Cost and Expenses 14.01 Million 9.67 Million 6.21 Million 3.99 Million 3.77 Million 1.92 Million
Operating Income -15.81 Million -9.67 Million -6.21 Million -3.98 Million -3.77 Million -1.92 Million
Interest Expense 33.64 Thousand 31.5 Thousand 22.95 Thousand 17.02 Thousand 20.93 Thousand 7247.87
Income Tax Expense -5269.86 -46.1 Thousand 41.51 Thousand -17.03 Thousand 2.00 -5.00
Earnings before Tax -13.69 Million -8.96 Million -4.35 Million -2.36 Million -1.59 Million -775.69 Thousand
Net Income -13.68 Million -8.92 Million -4.39 Million -2.34 Million -1.59 Million -775.69 Thousand
Earnings Per Share Basic -3.49 -2.67 -1.39 -0.95 -0.49 -0.24
Earnings Per Share Diluted -3.49 -2.67 -1.39 -0.95 -0.49 -0.24
Weighted Average Shares Outstanding 3.91 Million 3.33 Million 3.16 Million 2.47 Million 3.28 Million 3.28 Million
Weighted Average Shares Outstanding (Diluted) 3.91 Million 3.33 Million 3.16 Million 2.47 Million 3.28 Million 3.28 Million
Gross Margin - - - -358.06 -2320.37 -196.25
EBIT Margin - - - -348.71 -2485.38 -207.13
Profit Margin - - - -217.48 -1064.22 -84.29
EBITDA -13.22 Million -8.49 Million -3.95 Million -2.12 Million -1.52 Million -754.47 Thousand
Earnings Before Tax Margin - - - -369.35 -2517.64 -208.65

Income Statement Charts